nx-13
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 10, 2020 (NCT04458805)
Timeline
Indications
Studied for
Mechanism of action
- Fibroblast growth factor receptor 1ACTIVATOR
FGFR1 activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05785715 | Phase 2 | Apr 24, 2023 | Landos Biopharma Inc. |
| NCT04862741 | Phase 1 | May 5, 2021 | Landos Biopharma Inc. |
| NCT04458805 | Phase 1 | Jul 10, 2020 | Landos Biopharma Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Landos Biopharma Inc. | For profit | 3 | 3 | 2 | 2020 |
1 organizations
Page 1 / 1